Compare TU & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TU | PEN |
|---|---|---|
| Founded | 1993 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 12.6B |
| IPO Year | 2000 | 2015 |
| Metric | TU | PEN |
|---|---|---|
| Price | $8.33 | $322.51 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 18 | 17 |
| Target Price | $10.00 | ★ $362.54 |
| AVG Volume (30 Days) | ★ 5.6M | 325.8K |
| Earning Date | 11-06-2026 | 11-04-2026 |
| Dividend Yield | ★ 12.39% | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | N/A | ★ 1.70 |
| Revenue | N/A | ★ $1,403,665,000.00 |
| Revenue This Year | N/A | $13.46 |
| Revenue Next Year | $0.53 | $13.01 |
| P/E Ratio | ★ $25.82 | $188.85 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $7.64 | $221.26 |
| 52 Week High | $15.29 | $362.41 |
| Indicator | TU | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 46.86 | 59.07 |
| Support Level | $7.64 | $321.10 |
| Resistance Level | $10.11 | $324.05 |
| Average True Range (ATR) | 0.21 | 1.87 |
| MACD | 0.10 | 0.59 |
| Stochastic Oscillator | 82.35 | 89.64 |
Telus is one of Canada's Big Three telecom service providers, offering wireless and broadband services nationally, but with strongholds in British Columbia and Alberta. The firm serves 10 million postpaid and prepaid wireless customers. It counts nearly 3 million broadband customers across a network footprint that passes more than 4 million homes. The firm operates two additional segments, Telus Health and Telus Digital. Telus Health covers 170 million individuals, offering preventive medicine and virtual care in 200 countries. Telus Digital primarily offers third-party customer support, online content moderation, and data transformation.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.